Ron Squarer

Companies

• Nuvalent, Inc.Board member Dec 11, 2025 to now¹
• ADC Therapeutics SABoard member Jan 2, 2024 to now²
• Travere Therapeutics, Inc.Board member Apr 12, 2017 to now³
• Deciphera Pharmaceuticals, Inc.Board member Dec 6, 2019 to Jun 11, 2024⁴
• HospiraSVP, Global Marketing Jan 20, 2009 to Feb 28, 2011⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX39,375 shares⁶$2.1M at $53.15May 19, 2026
• ATADC Therapeutics SA ADCT123,431 shares⁷$172.8K at $1.40Jun 3, 2026
• NNuvalent, Inc.0 shares⁸Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 6,281 shares of Nuvalent, Inc.⁸
• Jun 16, 2026Granted 3,444 shares of Nuvalent, Inc.⁹
• Jun 3, 2026Shares withheld for tax 15,196 shares at $3.08 of ADC Therapeutics SA⁷
• Jun 1, 2026Granted 45,000 shares of ADC Therapeutics SA⁷
• May 19, 2026Granted 4,000 shares of Travere Therapeutics, Inc.⁶
• Dec 10, 2025Granted 2,837 shares of Nuvalent, Inc.¹⁰
• Jun 13, 2025Shares withheld for tax 15,184 shares at $3.58 of ADC Therapeutics SA¹¹
• Jun 3, 2025Granted 40,000 shares of ADC Therapeutics SA¹²
• May 15, 2025Granted 6,500 shares of Travere Therapeutics, Inc.¹³
• Jun 17, 2024Sold 6,995 shares at $2.89 of ADC Therapeutics SA¹⁴
• Jun 13, 2024Granted 40,000 shares of ADC Therapeutics SA¹⁵
• May 8, 2024Granted 6,500 shares of Travere Therapeutics, Inc.¹⁶
• May 17, 2023Granted 4,500 shares of Travere Therapeutics, Inc.¹⁷
• May 11, 2022Granted 3,000 shares of Travere Therapeutics, Inc.¹⁸